for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Inovio expands partnership with Advaccine for COVID-19 vaccine study

June 8 (Reuters) - Inovio Pharmaceuticals Inc on Tuesday expanded its partnership with Advaccine Biopharmaceuticals to conduct a late-stage trial of its COVID-19 vaccine candidate.

The company said the vaccine, INO-4800, will be tested among those who are 18 years and older across several countries, mainly in Latin America and Asia. (Reporting by Amruta Khandekar; Editing by Arun Koyyur)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up